Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Nicotinamidine hydrochloride → N-[4-Methyl-5-(2-pyridin-3-yl-pyrimidin-4-yl)-thiazol-2-yl]-acetamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Nicotinamidine hydrochloride | HCID 202042 | — |
| 반응물 | N-[4-Methyl-5-(2-morpholin-4-yl-pyrimidin-4-yl)-thiazol-2-yl]-acetamide | HCID 86610334 | — |
| 생성물 | N-[4-Methyl-5-(2-pyridin-3-yl-pyrimidin-4-yl)-thiazol-2-yl]-acetamide | HCID 11415694 | — |
반응 단계
The titled compound is prepared by an analogous procedure to N-[4-Methyl-5-(2-morpholin-4-yl-pyrimidin-4-yl)-thiazol-2-yl]-acetamide (25e) by replacing morpholinoformamidine hydrobromide (part 25c) with nicotinamidine hydrochloride.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08404684B2 |
| 출처 데이터셋 | uspto-grants-2013_03 |
| ORD ID | ord-82486817fdb842c9954f50ccb1a1b1a2 |
| 출처 메모 | uspto-grants-2013_03 |